MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Jeffery J et al. | Norethisterone interference in testosterone assays. | 2014 | Ann. Clin. Biochem. | pmid:24265092 |
Reyes M et al. | Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive. | 2014 | Eur. J. Clin. Pharmacol. | pmid:24362488 |
Polis CB et al. | Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. | 2014 | Contraception | pmid:25183264 |
Borghese B et al. | [Recurrence of pain after surgery for deeply infiltrating endometriosis: How does it happen? How to manage?]. | 2014 | J Gynecol Obstet Biol Reprod (Paris) | pmid:23265672 |
Blanchard K et al. | Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article. | 2014 | Contraception | pmid:24924260 |
Freudenberger T et al. | Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice. | 2014 | Br. J. Pharmacol. | pmid:24923668 |
Atrio J et al. | Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. | 2014 | J. Acquir. Immune Defic. Syndr. | pmid:24025339 |
Kogan P and Wald M | Male contraception: history and development. | 2014 | Urol. Clin. North Am. | pmid:24286773 |
Labos G et al. | Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23563111 |
Polis CB and Curtis KM | Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. | 2013 | Lancet Infect Dis | pmid:23871397 |